Filing Flows › Idexx Laboratories (IDXX) › Free cash flow
Idexx Laboratories (IDXX) free cash flow by quarter
Idexx Laboratories' free cash flow was $421M in Q3 2026 (third quarter 2026), +30% from Q2 2026. Over the last 7 quarters it ranged from $152M (Q2 2025) to $421M (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $421M | +30% | +13% |
| Q2 2026 | $323M | +38% | +113% |
| Q1 2026 | $234M | -28% | +13% |
| Q4 2025 | $326M | -12% | — |
| Q3 2025 | $371M | +145% | — |
| Q2 2025 | $152M | -27% | — |
| Q1 2025 | $208M | — | — |
Q3 2026 at a glance
Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.
Questions
What is Idexx Laboratories' free cash flow?
Idexx Laboratories' free cash flow was $421M in Q3 2026 (third quarter 2026), +30% from Q2 2026.
How has Idexx Laboratories' free cash flow changed?
Over the last 7 quarters it ranged from $152M (Q2 2025) to $421M (Q3 2026).